Intraperitoneal local anesthesia during laparoscopic cholecystectomy: the role of meta-analytical subgroups and delivery of the local anesthetic.

S. Purkayastha,N. Alkhamesi,A. Darzi

DOI: https://doi.org/10.1213/01.ANE.0000256079.45631.0F

2007-04-01

Abstract:ogy, progress with pediatric studies and labeling has been delayed. Following publication of data which might support a labeling change, it should be acknowledged that only the sponsor can request labeling changes, or special consideration for labeling changes can be considered at the initiative of the FDA. We are delighted to hear of the success of the correspondents in their preparation of the current trials by having contacted the FDA and used an Investigational New Drug application to support the current studies. This route should be considered for any new pharmaceutical that investigators believe will have significant impact in pediatric care but does not have the support of the sponsor. We are pleased to have had initial communications with the manufacturer of dexmedetomidine, Hospira, Inc., in initiating sponsor-funded pediatric trials. A Gordian Knot may not easily be untied, but one historical anecdote states that Alexander the Great “cut through it with a sword.” As Dr. Su and colleagues suggest, maybe the solution is not so complex if interested parties decide it is a priority. We appreciate the opportunity to focus attention on the easily disregarded needs of children’s health in anesthesia and other fields of medicine.